Your Location:
Home >
Browse articles >
Mechanism of Shenqi Yiliu Prescription Combined with Cisplatin on H22 Liver Cancer-bearing Mice Based on NLRP3/Caspase-1/GSDMD Pyroptosis Pathway
Mechanism of Shenqi Yiliu Prescription Combined with Cisplatin on H22 Liver Cancer-bearing Mice Based on NLRP3/Caspase-1/GSDMD Pyroptosis Pathway
- Chinese Journal of Experimental Traditional Medical Formulae Vol. 29, Issue 21, Pages: 114-122(2023)
DOI: 10.13422/j.cnki.syfjx.20230821
Scan QR Code
Full Text(HTML)
Figs( 5 ) Tabs( 8 )
References
Publication Info
Metrics
136
Views
101
Downloads
2
CSCD
Alert me when the article has been cited
Submit
Tools
- BibTeXDownload
- EndnoteDownload
- RefMan Download
- NoteExpressDownload
- NoteFirstDownload
Related Articles
Effect of Yiqi Yangyin Huoxue Prescription on NLRP3/Caspase-1/GSDMD Pyroptosis Pathway in Diabetic Kidney Disease Rats
Role of Spleen Failing to Disperse Essence-induced Macrophage Pyroptosis in Chronic Obstructive Pulmonary Disease and Intervention of Traditional Chinese Medicine: A Review
Shenqi Yiliu Prescription Reverses Cisplatin Resistance in Ovarian Cancer Cells by Regulating PI3K/Akt/mTOR Signaling Pathway-mediated Glycolysis
Study on Reducing Hepatotoxicity and Retaining Anti-osteoporosis Activity of Psoraleae Fructus Though Salt Processing Based on Zebrafish
Traditional Chinese Medicine Treatment of Colorectal Cancer Based on AMPK Signaling Pathway: A Review
Related Author
JIA Pingping
SONG Chundong
DUAN Fengyang
WANG Ningli
DING Ying
WANG Yaoxian
REN Xianqing
ZHAI Wensheng
Related Institution
Department of Pediatrics, The First Affiliated Hospital of Henan University of Traditional Chinese Medicine
Beijing University of Chinese Medicine
The First Affiliated Hospital of Guizhou University of TCM
Second People's Hospital of Guiyang
Guizhou University of Traditional Chinese Medicine(TCM)


